The non-zero percentage of use of diabetes medication (oral diabetes medication / insulin) at baseline observed in the “Control inclusion” group was likely individuals with pre-diabetes; while the negative values of “Years since type 2 diabetes diagnosis” observed were due to the individuals who received diabetes diagnosis sometime after their baseline visits (incident cases). The gene discussed is INS; the disease is diabetes mellitus.